SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Psylo, a leader in neurotherapeutics discovery and development, has officially rebranded as Xylo Bio. This transformation reflects the company's growth, ...
At the heart of Xylo's innovation is its computationally enhanced drug discovery platform, enabling the design and optimization of highly targeted neuroplastogens – a novel class of small molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback